Yes , history has showed us how far a biotech can go.
But this time, we will go far beyond and stay there because there are 2 types of biotech firms.
First type: Currently doing phase 1,2,3,- still in R& D ----( a.k.a. BMD PHASE----Burning Money Daily. Phase) ---90% failed phase 3.---recent firm failed phase 3....pps dropped from 16$ to 1$ now.
Second type: Done 1,2,3, 4---green light to go ahead ------>RD Done. ------->DEBTS GONE-----> CTO READY -----> CMT ....PPS 0.0242
We are severely undervalued.
KNOW WHAT YOU OWN.